Author

Ketil Tvermosegaard

GlaxoSmithKline (United Kingdom)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Andy D. BlanchardiD· 1 shared Carmel B. Nanthakumar· 1 shared Eleni PatiliiD· 1 shared Joanna C. BettsiD· 1 shared Klio MaratouiD· 1 shared Maria I. New· 1 shared Matteo Martufi· 1 shared Radu RapiteanuiD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Andy D. BlanchardORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Single step, high efficiency CRISPR-Cas9 genome editing in primary human disease-derived fibroblasts

Matteo Martufi, Robert B. Good, Radu Rapiteanu, Tobias Schmidt, Eleni Patili, Ketil Tvermosegaard, Maria I. New, Carmel B. Nanthakumar, Joanna C. Betts, Andy D. Blanchard, Klio Maratou

This study develops a single-step CRISPR-Cas9 method for high-efficiency genome editing in primary human fibroblasts without antibiotic selection or clonal expansion, achieving >90% knockout efficiency.

The CRISPR Journal · Feb 1, 2019Peer-reviewedMolecular Biology